Direxion Daily Healthcare Bull 3x Shares (CURE)
| Assets | $182.43M |
| Expense Ratio | 0.96% |
| PE Ratio | 26.12 |
| Shares Out | 1.70M |
| Dividend (ttm) | $1.92 |
| Dividend Yield | 1.71% |
| Ex-Dividend Date | Mar 19, 2024 |
| Payout Ratio | 44.76% |
| 1-Year Return | +24.32% |
| Volume | 45,913 |
| Open | 108.00 |
| Previous Close | 107.51 |
| Day's Range | 108.00 - 112.28 |
| 52-Week Low | 75.39 |
| 52-Week High | 127.50 |
| Beta | 1.67 |
| Holdings | 70 |
| Inception Date | Jun 15, 2011 |
About CURE
Fund Home PageThe Direxion Daily Healthcare Bull 3x Shares (CURE) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies. CURE was launched on Jun 15, 2011 and is issued by Direxion.
Top 10 Holdings
268.92% of assets| Name | Symbol | Weight |
|---|---|---|
| HEALTH CARE SELECT SECTOR INDEX SWAP | n/a | 122.26% |
| HEALTH CARE SELECT SECTOR INDEX SWAP | n/a | 53.57% |
| HEALTH CARE SELECT SECTOR INDEX SWAP | n/a | 43.00% |
| GOLDMAN FINL SQ TRSRY INST 506 | n/a | 11.80% |
| Eli Lilly and Company | LLY | 10.08% |
| UnitedHealth Group Incorporated | UNH | 6.91% |
| DREYFUS GOVT CASH MAN INS | n/a | 6.70% |
| Johnson & Johnson | JNJ | 5.43% |
| Merck & Co., Inc. | MRK | 4.90% |
| AbbVie Inc. | ABBV | 4.28% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 19, 2024 | $0.35548 | Mar 26, 2024 |
| Dec 21, 2023 | $0.57266 | Dec 29, 2023 |
| Sep 19, 2023 | $0.45383 | Sep 26, 2023 |
| Jun 21, 2023 | $0.53725 | Jun 28, 2023 |
| Mar 21, 2023 | $0.48743 | Mar 28, 2023 |
| Dec 20, 2022 | $0.14407 | Dec 28, 2022 |
News
Amid Monkeypox Outbreak, This 3X Leveraged ETF Provides Exposure To Health Sector: What To Watch
The Direxion Daily Healthcare Bull 3X Shares (NYSE: CURE) gapped up almost 2.52% higher on Monday in response to outbreaks of monkeypox being reported in several western nations. CURE is a triple leve...
Direxion Leveraged Healthcare ETF Ready To Make House Calls In 2021
Coronavirus vaccines are being distributed, but case counts continue rising, a pair of scenarios ensuring the healthcare center will again be an epicenter of activity in 2021. What Happened Healthcare...
Healthcare Sector Is Gonna Get Exciting, Capture That With CURE
The healthcare sector is shaking off rust accrued earlier this year and with the 2020 election season mostly behind the group – pending next month's Georgia Senate runoff elections – market observers ...
A CURE For The Common Earnings Play
It has the potential to be lost in this week's earnings hubbub, which is dominated by growth-ier communication services and technology stocks, but don't sleep on reports from blue-chip healthcare stoc...
3 Leveraged Healthcare ETFs Soaring This Month
The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidem...
Jablonski: Biotech presents a good buying opportunity
Sylvia Jablonski of Direxion discusses why biotech stocks and ETFs are attractive right now, due to their cheapness relative to the rest of the market.
It's Time To Consider Leveraged Healthcare ETFs
For traders using leveraged sector exchange-traded funds, one key to successfully using these products in the short-term fashion in which they are intended is to treat leveraged ETFs as event-driven t...